Literature DB >> 24867889

sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin.

Ryan C McCarthy1, Yun-Hee Park1, Daniel J Kosman2.   

Abstract

A sequence within the E2 domain of soluble amyloid precursor protein (sAPP) stimulates iron efflux. This activity has been attributed to a ferroxidase activity suggested for this motif. We demonstrate that the stimulation of efflux supported by this peptide and by sAPPα is due to their stabilization of the ferrous iron exporter, ferroportin (Fpn), in the plasma membrane of human brain microvascular endothelial cells (hBMVEC). The peptide does not bind ferric iron explaining why it does not and thermodynamically cannot promote ferrous iron autoxidation. This peptide specifically pulls Fpn down from the plasma membrane of hBMVEC; based on these results, FTP, for ferroportin-targeting peptide, correctly identifies the function of this peptide. The data suggest that in stabilizing Fpn via the targeting due to the FTP sequence, sAPP will increase the flux of iron into the cerebral interstitium. This inference correlates with the observation of significant iron deposition in the amyloid plaques characteristic of Alzheimer's disease.
© 2014 The Authors.

Entities:  

Keywords:  blood‐brain barrier; brain iron metabolism; ferroportin; iron transport; sAPP

Mesh:

Substances:

Year:  2014        PMID: 24867889      PMCID: PMC4196985          DOI: 10.15252/embr.201338064

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  54 in total

Review 1.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

Review 2.  Metallostasis in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Free Radic Biol Med       Date:  2012-11-09       Impact factor: 7.376

3.  Brain endothelial cells produce amyloid {beta} from amyloid precursor protein 770 and preferentially secrete the O-glycosylated form.

Authors:  Shinobu Kitazume; Yuriko Tachida; Masaki Kato; Yoshiki Yamaguchi; Takashi Honda; Yasuhiro Hashimoto; Yoshinao Wada; Takashi Saito; Nobuhisa Iwata; Takaomi Saido; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

4.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse.

Authors:  C D Vulpe; Y M Kuo; T L Murphy; L Cowley; C Askwith; N Libina; J Gitschier; G J Anderson
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

Review 5.  Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.

Authors:  Orly Weinreb; Silvia Mandel; Moussa B H Youdim; Tamar Amit
Journal:  Free Radic Biol Med       Date:  2013-01-30       Impact factor: 7.376

Review 6.  Multicopper oxidases: a workshop on copper coordination chemistry, electron transfer, and metallophysiology.

Authors:  Daniel J Kosman
Journal:  J Biol Inorg Chem       Date:  2009-10-09       Impact factor: 3.358

7.  In vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties.

Authors:  Fuyuko Takata; Shinya Dohgu; Atsushi Yamauchi; Junichi Matsumoto; Takashi Machida; Kayoko Fujishita; Keisuke Shibata; Youichi Shinozaki; Kaoru Sato; Yasufumi Kataoka; Schuichi Koizumi
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

8.  A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells.

Authors:  Adjanie Patabendige; Robert A Skinner; Louise Morgan; N Joan Abbott
Journal:  Brain Res       Date:  2013-04-17       Impact factor: 3.252

9.  The amyloid precursor protein (APP) does not have a ferroxidase site in its E2 domain.

Authors:  Kourosh Honarmand Ebrahimi; Christian Dienemann; Sandra Hoefgen; Manuel E Than; Peter-Leon Hagedoorn; Wilfred R Hagen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

10.  A synthetic peptide with the putative iron binding motif of amyloid precursor protein (APP) does not catalytically oxidize iron.

Authors:  Kourosh Honarmand Ebrahimi; Peter-Leon Hagedoorn; Wilfred R Hagen
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

View more
  50 in total

Review 1.  Neurotoxicity Linked to Dysfunctional Metal Ion Homeostasis and Xenobiotic Metal Exposure: Redox Signaling and Oxidative Stress.

Authors:  Carla Garza-Lombó; Yanahi Posadas; Liliana Quintanar; María E Gonsebatt; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2018-03-28       Impact factor: 8.401

2.  Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders.

Authors:  Niels Bergsland; Eleonora Tavazzi; Ferdinand Schweser; Dejan Jakimovski; Jesper Hagemeier; Michael G Dwyer; Robert Zivadinov
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

3.  APPealing for a role in cellular iron efflux.

Authors:  Debomoy K Lahiri; Bryan Maloney; Ruizhi Wang
Journal:  J Biol Chem       Date:  2019-06-14       Impact factor: 5.157

Review 4.  Treating Alzheimer's disease by targeting iron.

Authors:  Sara Nikseresht; Ashley I Bush; Scott Ayton
Journal:  Br J Pharmacol       Date:  2019-02-11       Impact factor: 8.739

5.  Manganese causes neurotoxic iron accumulation via translational repression of amyloid precursor protein and H-Ferritin.

Authors:  Vivek Venkataramani; Thorsten R Doeppner; Desiree Willkommen; Catherine M Cahill; Yongjuan Xin; Guilin Ye; Yanyan Liu; Adam Southon; Allegra Aron; Ho Yu Au-Yeung; Xudong Huang; Debomoy K Lahiri; Fudi Wang; Ashley I Bush; Gerald G Wulf; Philipp Ströbel; Bernhard Michalke; Jack T Rogers
Journal:  J Neurochem       Date:  2018-11-19       Impact factor: 5.372

6.  Lithium suppression of tau induces brain iron accumulation and neurodegeneration.

Authors:  P Lei; S Ayton; A T Appukuttan; S Moon; J A Duce; I Volitakis; R Cherny; S J Wood; M Greenough; G Berger; C Pantelis; P McGorry; A Yung; D I Finkelstein; A I Bush
Journal:  Mol Psychiatry       Date:  2016-07-12       Impact factor: 15.992

Review 7.  Molecular Mechanisms of Metal Toxicity in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Tanvir Kabir; Md Sahab Uddin; Sonia Zaman; Yesmin Begum; Ghulam Md Ashraf; May N Bin-Jumah; Simona G Bungau; Shaker A Mousa; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-05       Impact factor: 5.590

8.  The Ferroxidase Hephaestin But Not Amyloid Precursor Protein is Required for Ferroportin-Supported Iron Efflux in Primary Hippocampal Neurons.

Authors:  Changyi Ji; Brittany L Steimle; Danielle K Bailey; Daniel J Kosman
Journal:  Cell Mol Neurobiol       Date:  2017-11-25       Impact factor: 5.046

9.  Is brain iron trafficking part of the physiology of the amyloid precursor protein?

Authors:  Danielle K Bailey; Daniel J Kosman
Journal:  J Biol Inorg Chem       Date:  2019-10-01       Impact factor: 3.358

10.  Fluorescence resonance energy transfer links membrane ferroportin, hephaestin but not ferroportin, amyloid precursor protein complex with iron efflux.

Authors:  Adrienne C Dlouhy; Danielle K Bailey; Brittany L Steimle; Haley V Parker; Daniel J Kosman
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.